From: Aspergillus fumigatus during COPD exacerbation: a pair-matched retrospective study
Characteristics | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
OR (95% CI) | p value | OR (95% CI) | p value | |
BMI | 0.929 (0.817–1.057) | 0.264 | ||
Smoking history | 0.270 (0.077–0.944) | 0.040 | 0.275 (0.073–1.036) | 0.056 |
Pack-years | 1.008 (0.994–1.022) | 0.291 | ||
FEV1% pre (post bronchodilators) | 0.982 (0.951–1.014) | 0.259 | ||
GOLD grade | 1.968 (0.638–6.075) | 0.239 | ||
Hypertension | 1.280 (0.479–3.424) | 0.622 | ||
Diabetes mellitus | 1.719 (0.593–4.983) | 0.319 | ||
Coronary heart disease | 1.449 (0.507–4.139) | 0.488 | ||
Cerebral vascular disease | 1.242 (0.349–4.421) | 0.738 | ||
Chronic heart failure | 2.533 (0.878–7.313) | 0.086 | 3.147 (0.978–10.130) | 0.055 |
Chronic renal failure | 2.095 (0.328–13.397) | 0.435 | ||
Corticosteroids use | 4.149 (1.456–11.825) | 0.008 | 4.685 (1.529–14.355) | 0.007 |
Long term oxygen therapy | 0.713 (0.182–2.787) | 0.626 | ||
Times of AECOPD in previous year | 1.299 (0.880–1.918) | 0.188 |